Home > Healthcare > Biotechnology > Biotechnology R&D > Proteinase K Market

Proteinase K Market Share

Report ID: GMI11996
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Proteinase K Market Share

The competition in the market is characterized by intense rivalry, fuelled by the growing demand for proteinase K. Alongside global leaders, advanced formulations tailored for specific advantages or precise outcomes are emerging, particularly in regions like North America, where technological advancements are highly emphasized. New innovations in proteinase K are a key competitive factor, with companies partnering with other manufacturers or research organizations to develop high-quality proteinase K solutions that deliver efficient results. Thus, continuous innovation and advancements are crucial for staying competitive in this fast-evolving industry.

Proteinase K Market Companies

Prominent players operating in the proteinase K industry include:

Abcam
Agilent Technologies
Bioline (Meridian Biosciences)
BIORON
F. Hoffmann-La Roche
Merck
Minerva Biolabs
MP BIOMEDICALS
New England Biolabs
Norgen Biotek
Promega Corporation
QIAGEN
Sisco Research Laboratories
Takara Bio
Thermo Fisher Scientific

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global proteinase K industry was valued at approximately USD 1.3 billion in 2023 and is estimated to grow at a 7.5% CAGR from 2024 to 2032, driven by the increasing prevalence of chronic and infectious diseases and advancements in biotechnology.

The powdered proteinase K segment dominated the market in 2023, accounting for USD 735.7 million, due to its greater stability, longer shelf life, and easier storage conditions compared to its liquid counterpart.

U.S. led the North American proteinase K market with revenues of USD 456.2 million in 2023, supported by numerous academic and research institutions engaged in genetic and cellular research and increased federal funding for scientific research.

Key players in the proteinase K industry include Abcam, Agilent Technologies, Bioline (Meridian Biosciences), BIORON, F. Hoffmann-La Roche, Merck, Minerva Biolabs, MP BIOMEDICALS, New England Biolabs, and Norgen Biotek.